The Cannabist Company Holdings Inc. (CBSTF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Cannabist Company Holdings Inc. (CBSTF) with AI Score 42/100 (Grade C). The Cannabist Company Holdings Inc. cultivates, manufactures, and provides cannabis products and related services across the United States and internationally. Sector: Healthcare.
Last analyzed: Mar 17, 2026CBSTF: the 1 perspectives are evenly split.
How is this calculated? →The Cannabist Company Holdings Inc. (CBSTF) Healthcare & Pipeline Overview
The Cannabist Company Holdings Inc. operates in the cannabis industry, cultivating, manufacturing, and distributing a variety of cannabis products. With licenses in 17 U.S. jurisdictions, the company offers flower, edibles, oils, and tablets under multiple brands, positioning itself in the competitive and evolving cannabis market.
What Is the Investment Thesis for CBSTF?
The Cannabist Company Holdings Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's multi-state presence, with licenses in 17 jurisdictions, provides a foundation for growth as legalization expands. However, the company's negative P/E ratio of -0.07 and a negative profit margin of -51.2% indicate significant financial challenges. The gross margin of 29.5% suggests potential for improvement through operational efficiencies and strategic pricing. Key catalysts include potential regulatory changes and expansion into new markets. Investors should closely monitor the company's ability to achieve profitability and manage its operational costs. The company's beta of 0.75 suggests lower volatility compared to the overall market.
Based on FMP financials and quantitative analysis
CBSTF Key Highlights
- Market capitalization of $0.01 billion indicates a small-cap company with potential for growth but also higher risk.
- Negative P/E ratio of -0.07 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Profit margin of -51.2% highlights significant operational challenges and the need for improved cost management.
- Gross margin of 29.5% suggests potential for profitability if operational efficiencies are improved.
- Licenses in 17 U.S. jurisdictions provide a substantial footprint for expansion as cannabis legalization progresses.
Who Are CBSTF's Competitors?
CBSTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CANSF Atlas Energy Corp. | $0.10 | -13.93% | $36.98M | 44 |
| CNTMF Fluent Corp. | $0.02 | -0.80% | $10.45M | 45 |
| ELIXF Elixxer Ltd. | $0.03 | +0.00% | $23.35M | 48 |
| GHBWF Glass House Brands Inc. | $0.13 | +8.33% | $10.65M | 51 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CBSTF's Key Strengths?
- Licenses in 17 U.S. jurisdictions.
- Diverse product portfolio.
- Established brand names.
- Vertical integration.
What Are CBSTF's Weaknesses?
- Negative profit margin.
- High operational costs.
- Limited brand recognition compared to larger competitors.
- Dependence on regulatory changes.
What Could Drive CBSTF Stock Higher?
- Expansion into new markets as cannabis legalization progresses.
- Product innovation and diversification to meet evolving consumer preferences.
- Potential regulatory changes at the state or federal level.
- Strategic partnerships and acquisitions to expand market reach.
- Efforts to improve operational efficiency and reduce costs.
What Are the Key Risks for CBSTF?
- Financial-distress signal — its Altman Z-Score of -3.31 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Intense competition from other cannabis companies.
- Regulatory uncertainty and changing laws.
- Fluctuations in cannabis prices.
- Negative public perception of cannabis.
- Limited access to capital due to the nature of the business.
What Are the Growth Opportunities for CBSTF?
- Expansion into New Markets: As cannabis legalization continues to spread across the United States and internationally, The Cannabist Company has the opportunity to expand its operations into new markets. Each new state or country that legalizes cannabis represents a potential revenue stream and growth opportunity. The timeline for this growth is dependent on the pace of legalization efforts, but the long-term trend is toward greater acceptance and accessibility. The company's existing licenses in 17 U.S. jurisdictions provide a strong foundation for further expansion.
- Product Innovation and Diversification: The Cannabist Company can drive growth by innovating and diversifying its product offerings. This includes developing new cannabis-infused products, exploring different consumption methods, and catering to specific consumer preferences. The market for cannabis-infused beverages, edibles, and wellness products is growing rapidly, presenting opportunities for the company to capture new market segments. The timeline for product development and launch is relatively short, allowing the company to quickly adapt to changing consumer demands.
- Strategic Partnerships and Acquisitions: The Cannabist Company can accelerate its growth through strategic partnerships and acquisitions. Collaborating with other companies in the cannabis industry, such as technology providers, distribution networks, or retail operators, can enhance its operational capabilities and market reach. Acquiring smaller companies with complementary products or technologies can also drive growth and expand its market share. The timeline for partnerships and acquisitions varies depending on the specific opportunities, but these strategies can provide significant growth potential in the medium to long term.
- Brand Building and Marketing: Investing in brand building and marketing is crucial for The Cannabist Company to differentiate itself from competitors and attract new customers. Developing strong brand recognition and loyalty can drive sales and increase market share. This includes creating compelling marketing campaigns, engaging with consumers through social media, and sponsoring events. The timeline for brand building is ongoing, requiring consistent effort and investment over the long term. A strong brand can command premium pricing and create a sustainable competitive advantage.
- Operational Efficiency and Cost Optimization: Improving operational efficiency and optimizing costs can significantly enhance The Cannabist Company's profitability and competitiveness. This includes streamlining its cultivation and manufacturing processes, reducing waste, and optimizing its supply chain. Implementing technology solutions, such as automation and data analytics, can also drive efficiency and reduce costs. The timeline for operational improvements is ongoing, requiring continuous monitoring and optimization. Increased efficiency can lead to higher gross margins and improved financial performance.
What Opportunities Does CBSTF Have?
- Expansion into new markets as legalization progresses.
- Product innovation and diversification.
- Strategic partnerships and acquisitions.
- Increasing demand for cannabis products.
What Threats Does CBSTF Face?
- Intense competition.
- Regulatory uncertainty.
- Fluctuations in cannabis prices.
- Negative public perception of cannabis.
What Are CBSTF's Competitive Advantages?
- Licenses: Holding licenses in 17 U.S. jurisdictions creates a barrier to entry.
- Brand Portfolio: A diverse portfolio of brands caters to different consumer segments.
- Vertical Integration: Controlling the cultivation, manufacturing, and distribution processes provides greater control over the supply chain and product quality.
What Does CBSTF Do?
The Cannabist Company Holdings Inc., formerly known as Columbia Care Inc., was founded in 2012 and rebranded in September 2023. Headquartered in New York City, the company operates in the cannabis industry, focusing on the cultivation, manufacturing, and distribution of cannabis products and related services. The company's product offerings include flower, edibles, oils, and tablets, marketed under brand names such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber. The Cannabist Company holds licenses in 17 jurisdictions within the United States, allowing it to operate across multiple states. This multi-state presence is crucial in the fragmented legal landscape of the cannabis industry in the U.S. The company aims to cater to a broad spectrum of consumer preferences through its diverse product portfolio. By offering a range of consumption methods and product types, The Cannabist Company seeks to capture different segments of the cannabis market. The company's strategic focus includes expanding its brand presence and optimizing its operational efficiency within existing markets. The Cannabist Company navigates the complex regulatory environment of the cannabis industry to establish a strong foothold in key markets.
What Products and Services Does CBSTF Offer?
- Cultivates cannabis plants in licensed facilities.
- Manufactures a variety of cannabis products, including flower, edibles, oils, and tablets.
- Distributes cannabis products through its own retail locations and wholesale channels.
- Markets its products under various brand names, such as Seed & Strain, Triple Seven, and Hedy.
- Holds licenses to operate in 17 jurisdictions in the United States.
- Provides cannabis-related services to consumers and businesses.
How Does CBSTF Make Money?
- Cultivation and Manufacturing: The company grows cannabis and manufactures various cannabis products.
- Retail Sales: The company sells its products directly to consumers through its own retail stores.
- Wholesale Distribution: The company distributes its products to other retailers and dispensaries.
What Industry Does CBSTF Operate In?
The Cannabist Company operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and market expansion. The U.S. cannabis market is projected to reach significant growth in the coming years, driven by both medical and recreational use. The competitive landscape includes both large multi-state operators and smaller regional players. Companies like CANSF (Columbia Care Cannabis Corp), CNTMF (Cresco Labs Inc.), DXBRF (Dixie Brands Inc.), ELIXF (Elixinol Wellness Limited), and GHBWF (Greenlane Holdings Inc.) represent key competitors, each vying for market share through different strategies, such as brand differentiation, geographic expansion, and product innovation. The industry faces regulatory hurdles and varying state laws, requiring companies to navigate a complex legal environment.
Who Are CBSTF's Key Customers?
- Adult recreational cannabis users.
- Patients with medical cannabis prescriptions.
- Wholesale clients, including other dispensaries and retailers.
Net buyingInsider Activity
The most recent 10 insider filings for The Cannabist Company Holdings Inc. break down as 3 sales and 7 purchases. On net that is roughly 4.6M shares acquired (about $70) — insiders putting money in tends to read as conviction.
FY2026 estForward Outlook
Wall Street analysts project The Cannabist Company Holdings Inc. revenue of about $336.0M for fiscal 2026, with EPS near $-0.13.
F-Score 1/9Financial Health
The Cannabist Company Holdings Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.31 places it in the distress zone, a signal of elevated financial risk.
ROE 189%Key Financial Metrics
Return on equity for The Cannabist Company Holdings Inc. stands at 188.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -33.4%, showing how much profit it generates from its asset base. A current ratio of 0.89 means current liabilities exceed short-term assets, a liquidity point worth watching.
The Cannabist Company Holdings Inc. (CBSTF) Valuation Context
Relative to its peer group, CBSTF's quantitative score of 42/100 is roughly in line with the peer average of 51/100.
CBSTF Revenue & Earnings Trend
In Q3 2025, CBSTF generated $79.9M in top-line revenue, marking a sequential decrease of 7.5%. The company recorded a net loss of $14.3M, with diluted EPS of $-0.03. Revenue has contracted over three consecutive quarters, which investors in this unknown Healthcare stock should monitor closely. Across the four most recent quarters, CBSTF averaged $-0.09 in diluted EPS.
Company Profile
The Cannabist Company Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in New York City, US. The company is led by CEO David J. Hart. CBSTF has traded publicly since 2019.
CBSTF Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that those closest to the business believe in its potential.
- Community sentiment has turned increasingly positive, with discussions highlighting the company's innovative product lines and market strategies.
- The cannabis sector is seeing renewed interest as regulatory changes are anticipated, positioning Cannabist to benefit from a more favorable landscape.
- Recent partnerships with established brands have enhanced Cannabist's market presence, attracting attention from both consumers and investors.
Bear Case
- Concerns over regulatory hurdles persist, with potential delays in legislation that could impact growth and market access for Cannabist.
- Community sentiment has also seen bearish voices expressing skepticism about the long-term viability of cannabis companies amidst market saturation.
- Insider selling activity in the past raised red flags about the company's short-term outlook, leading to doubts about sustained performance.
- Economic uncertainties may affect discretionary spending on cannabis products, which could impact Cannabist's sales in the near term.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $80M | -$14M | -$0.03 |
| Q2 2025 | $86M | -$78M | -$0.16 |
| Q1 2025 | $87M | -$32M | -$0.07 |
| Q4 2024 | $96M | -$55M | -$0.12 |
Based on FMP financials and quantitative analysis
CBSTF Latest News
No recent news available for CBSTF.
CBSTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBSTF.
Price Targets
Wall Street price target analysis for CBSTF.
CBSTF MoonshotScore
What does this score mean?
The MoonshotScore rates CBSTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David J. Hart
Unknown
Information on David J. Hart's background is not available in the provided context. Without additional data, it is impossible to provide details on his career history, education, or previous roles.
Track Record: Information on David J. Hart's track record is not available in the provided context. Without additional data, it is impossible to provide details on his key achievements, strategic decisions, or company milestones under his leadership.
CBSTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that The Cannabist Company Holdings Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB, or major exchanges like NYSE or NASDAQ. Companies in this tier often have limited operating history, may be thinly traded, and are subject to less stringent regulatory oversight. This tier is typically associated with higher risk and requires greater due diligence from investors compared to companies listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume.
- Less stringent regulatory oversight compared to major exchanges.
- Higher price volatility.
- Potential for limited or delayed financial reporting.
- Increased risk of fraud or manipulation.
- Verify the company's legal status and registration.
- Review available financial statements and disclosures.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Evaluate the company's risk factors and potential liabilities.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has been in operation since 2012.
- The company holds licenses in 17 U.S. jurisdictions.
- The company has a diverse product portfolio.
- The company has a physical headquarters in New York City.
CBSTF Healthcare Stock FAQ
What does The Cannabist Company Holdings Inc. do?
The Cannabist Company Holdings Inc. cultivates, manufactures, and distributes a range of cannabis products, including flower, edibles, oils, and tablets, under various brand names. They operate in 17 U.S. jurisdictions, navigating the complex regulatory landscape of the cannabis industry. The company aims to cater to both recreational and medical cannabis users through its diverse product portfolio and multi-state presence. Their business model encompasses cultivation, manufacturing, retail sales, and wholesale distribution, positioning them as a vertically integrated player in the cannabis market.
What are the main risks for CBSTF?
The Cannabist Company faces several key risks, including intense competition in the cannabis industry, regulatory uncertainty, and fluctuations in cannabis prices. The company's negative profit margin and high operational costs pose significant financial challenges. As an OTC-listed company, CBSTF is subject to less stringent regulatory oversight and faces liquidity risks. Dependence on regulatory changes and potential negative public perception of cannabis also present ongoing risks. Investors should carefully consider these factors before investing.
What revenue streams does The Cannabist Company Holdings Inc. have in healthcare?
The Cannabist Company Holdings Inc. generates revenue through the sale of cannabis products, including flower, edibles, oils, and tablets, to both medical and recreational users. The company's revenue streams are geographically diversified across the 17 U.S. jurisdictions where it holds licenses. While specific revenue breakdowns by product line and therapeutic area are not available, the company's focus on both medical and recreational markets provides multiple avenues for revenue generation. The company's ability to expand its product offerings and market reach will be crucial for driving future revenue growth.
How does The Cannabist Company Holdings Inc. compete with larger cannabis companies?
The Cannabist Company Holdings Inc. competes with larger cannabis companies through a combination of strategic differentiation and operational focus. While lacking the scale and resources of larger multi-state operators, The Cannabist Company leverages its established brand names, diverse product portfolio, and licenses in key markets to carve out a competitive niche. The company focuses on product innovation, catering to specific consumer preferences, and building strong brand loyalty. Strategic partnerships and acquisitions can also enhance its competitive position. By optimizing its operational efficiency and cost structure, The Cannabist Company aims to compete effectively within the evolving cannabis landscape.
What are the key factors to evaluate for CBSTF?
The Cannabist Company Holdings Inc. (CBSTF) holds an AI score of 42/100 (low). Not financial advice.
How frequently does CBSTF data refresh on this page?
CBSTF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CBSTF's recent stock price performance?
The Cannabist Company Holdings Inc. (CBSTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Licenses in 17 U.S. jurisdictions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CBSTF overvalued or undervalued right now?
Valuing The Cannabist Company Holdings Inc. (CBSTF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Financial data may not be fully up-to-date due to the nature of the OTC listing.